Locations
San Diego, CA, USA
industry
Biotechnology · DeepTech
Size
11-50 employees
Stage
Series A
founded in
2022
Zafrens is a pioneering drug discovery company that leverages advanced nanofabrication techniques to analyze and manipulate cells at unprecedented resolution and throughput. Their innovative platform enables the performance of up to 200,000 experiments simultaneously, democratizing access to therapeutics across various modalities. By linking molecular states of cells to their functional manifestations, Zafrens is positioned to drive significant advancements in life sciences, particularly in small molecule drug discovery and T cell analysis. Their unique approach not only enhances the understanding of complex biological systems but also accelerates the drug discovery process, making them a key player in the market.
Is this your company?
Something looks off?